Similar articles

• Simultaneous analysis of the single and multiple dose pharmacokinetics of the non-steroidal anti-inflammatory, alclofenac.

  Sennello LT, Sonders RC, Jochimsen WG, Friedmann N. Sennello LT, et al. J Int Med Res. 1979;7(4):253-62. doi: 10.1177/030006057900700401. J Int Med Res. 1979. PMID: 39855 Clinical Trial. No abstract available.
• Pharmacokinetics and availability of alclofenac in man after the administration of different pharmaceutical forms and doses.

  Testa R. Testa R. Farmaco Prat. 1978 Aug;33(8):333-42. Farmaco Prat. 1978. PMID: 34526 No abstract available.
• Pharmacokinetics and bioavailability of alclofenac and its lysine-salt after different route of administration in the rabbit.

  Testa R, Airoldi L, Latini R. Testa R, et al. Pharmacol Res Commun. 1978 Jan;10(1):53-63. doi: 10.1016/s0031-6989(78)80062-9. Pharmacol Res Commun. 1978. PMID: 25443 No abstract available.
• Evaluation of alclofenac treatment regimes in man.

  Benedetti MS, Strolin P, Roncucci R, Simon MJ, Lambelin G, Nagant de Deuxchaisnes C. Benedetti MS, et al. Eur J Clin Pharmacol. 1973 Dec;6(4):261-7. doi: 10.1007/BF00644743. Eur J Clin Pharmacol. 1973. PMID: 4204721 No abstract available.
• [Hepatitis caused by new nonsteroidal anti-inflammatory agents].

  Babany G, Pessayre D. Babany G, et al. Gastroenterol Clin Biol. 1984 Jun-Jul;8(6-7):523-9. Gastroenterol Clin Biol. 1984. PMID: 6378709 Review. French. No abstract available.